Invest in

Fighting Fat


Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
55.6% Diabetes Care 2.1%
17.7% Merck & Company Inc. (new) MRK 20.8%
17.1% Novo Nordisk A/S NVO 12.8%
14.3% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 17.3%
3.2% Astrazeneca Plc ADR AZN 10.5%
1.9% Alkermes plc ALKS 25.3%
1.4% Integer Holdings Corporation ITGR --
37.5% Weight Management 17.1%
15.4% NutriSystem Inc NTRI 5.9%
4.1% Nu Skin Enterprises Inc. (A) NUS 32.8%
3.9% Weight Watchers International Inc WTW 74.8%
2.4% USANA Health Sciences Inc. USNA 6.9%
1.8% Vitamin Shoppe Inc VSI 24.9%
1.7% GNC Holdings Inc. Class A GNC 57.0%
6.9% Weight Loss Drugs 39.9%
6.9% Arena Pharmaceuticals Inc. ARNA 39.9%

Quotes delayed 15 mins. Currently Aug 31, 2016 12:17:33 AM. Fields are marked with -- when data is unavailable.